{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04697719",
            "orgStudyIdInfo": {
                "id": "20-01884"
            },
            "organization": {
                "fullName": "NYU Langone Health",
                "class": "OTHER"
            },
            "briefTitle": "Body Weight, Aspirin Dose and Pro-resolving Mediators",
            "officialTitle": "DISCOVER: A Single-site Double-blind Placebo-controlled Randomized Mechanistic Crossover Trial to Assess the Influence of boDy weIght on aSpirin-triggered speCialized prO-resolVing mEdiatoRs",
            "therapeuticArea": [
                "Other"
            ],
            "study": "body-weight-aspirin-dose-and-pro-resolving-mediators"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-11-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-01-04",
            "studyFirstSubmitQcDate": "2021-01-04",
            "studyFirstPostDateStruct": {
                "date": "2021-01-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "NYU Langone Health",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This study employs a placebo-controlled randomized cross-over design to investigate the impact of body weight and aspirin dose on levels of specialized pro-resolving lipid mediators in blood and neutrophils."
        },
        "conditionsModule": {
            "conditions": [
                "Body Weight"
            ],
            "keywords": [
                "Aspirin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "This is a two-phase crossover design with run-in and wash out periods prior to each phase.",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 125,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Aspirin 81mg, Then Aspirin 325mg",
                    "type": "EXPERIMENTAL",
                    "description": "After a 3 week placebo run-in period, participants first receive Aspirin 81mg capsule daily for 3 weeks. After a placebo washout period of 3 weeks, they then receive Aspirin 325mg capsule daily for another 3 weeks.",
                    "interventionNames": [
                        "Drug: Aspirin 81mg",
                        "Drug: Aspirin 325mg"
                    ]
                },
                {
                    "label": "Aspirin 325mg, Then Aspirin 81mg",
                    "type": "EXPERIMENTAL",
                    "description": "After a 3 week placebo run-in period, participants first receive Aspirin 325mg capsule daily for 3 weeks. After a placebo washout period of 3 weeks, they then receive Aspirin 81mg capsule daily for another 3 weeks.",
                    "interventionNames": [
                        "Drug: Aspirin 81mg",
                        "Drug: Aspirin 325mg"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Aspirin 81mg",
                    "description": "81mg oral capsule",
                    "armGroupLabels": [
                        "Aspirin 325mg, Then Aspirin 81mg",
                        "Aspirin 81mg, Then Aspirin 325mg"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Aspirin 325mg",
                    "description": "325mg oral capsule",
                    "armGroupLabels": [
                        "Aspirin 325mg, Then Aspirin 81mg",
                        "Aspirin 81mg, Then Aspirin 325mg"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Serum 15R-LXA4",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in Serum 15R-LXA4",
                    "timeFrame": "Week 9, Week 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in serum and neutrophil supernatant lipid mediators",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in serum and neutrophil supernatant lipid mediators",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in platelet-monocyte aggregates",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in platelet-monocyte aggregates",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in platelet-neutrophil aggregates",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in platelet-neutrophil aggregates",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in platelet surface expression of CD62P",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in platelet surface expression of CD62P",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in leukocyte expression of ALX/FPR2",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in leukocyte expression of ALX/FPR2",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in leukocyte expression of GPR32",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in leukocyte expression of GPR32",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in leukocyte expression of ERV1/ChemR23",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in leukocyte expression of ERV1/ChemR23",
                    "timeFrame": "Week 9, Week 12"
                },
                {
                    "measure": "Change in leukocyte expression of BLT1",
                    "timeFrame": "Week 3, Week 6"
                },
                {
                    "measure": "Change in leukocyte expression of BLT1",
                    "timeFrame": "Week 9, Week 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age between 40 and 70 years\n\nExclusion Criteria:\n\n1. Anti-platelet medication use in the past 7 days\n2. Aspirin intolerance or allergy\n3. Known bleeding or clotting disorder\n4. Chronic inflammatory or connective tissue disease\n5. Immunological deficiency\n6. Diabetes mellitus\n7. Prior gastric or bariatric surgery\n8. Active smoking\n9. Platelet count \\<100,000\n10. Use of omega-3 fatty acid supplementation\n11. Use of drugs or supplements known to inhibit COX-1/COX-2/lipoxygenases\n12. Corticosteroid use\n13. Recent initiation or change in dose of statin therapy\n14. Pregnancy",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "40 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sean Heffron, MD",
                    "role": "CONTACT",
                    "phone": "212-263-0855",
                    "email": "sean.heffron@nyulangone.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sean Heffron, MD",
                    "affiliation": "NYU Langone Health",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sean Heffron, MD",
                            "role": "CONTACT",
                            "email": "Sean.Heffron@nyulangone.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.",
            "accessCriteria": "The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to sean.heffron@nyulangone.org. To gain access, data requestors will need to sign a data access agreement."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "asFound": "Body Weight",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001241",
                    "term": "Aspirin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000894",
                    "term": "Anti-Inflammatory Agents, Non-Steroidal"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000005343",
                    "term": "Fibrinolytic Agents"
                },
                {
                    "id": "D000050299",
                    "term": "Fibrin Modulating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000010975",
                    "term": "Platelet Aggregation Inhibitors"
                },
                {
                    "id": "D000016861",
                    "term": "Cyclooxygenase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000058633",
                    "term": "Antipyretics"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4548",
                    "name": "Aspirin",
                    "asFound": "Vitamin",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4218",
                    "name": "Anti-Inflammatory Agents, Non-Steroidal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8473",
                    "name": "Fibrinolytic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M13865",
                    "name": "Platelet Aggregation Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19209",
                    "name": "Cyclooxygenase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29176",
                    "name": "Antipyretics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Antipy",
                    "name": "Antipyretics"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "FiAg",
                    "name": "Fibrinolytic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}